This study will focus on the acute effects of ethanol in combination with other commonly used drugs on biomembrane structure and both enzyme and receptor function. Among the drugs to be studied are pentobarbital, chlorpromazine, and diazepam. Such drugs, in the presence of ethanol, are associated with enhanced psychomotor impairment and respiratory depression. Separately these drugs and ethanol alter membrane fluidity. Furthermore, pentobarbital and ethanol exhibit cross-tolerance in both inhibition of the righting reflex of the rat and perturbation of fluidity in mice synaptosomal membranes. Indeed, there is much evidence that the physiological effects of ethanol alone and of many other drugs are connected with the fluidization, penetration, and/or alteration of transition temperatures of cell membranes. Such parameters will be quantitated in synaptosomal and liver plasma membranes by ESR spectroscopy under varying perturbant conditions. Once significant structural alterations are verified, changes in activities of membrane-bound enzymes such as the Na+/K+ dependent ATPase and acetylcholinesterase, as well as changes in receptor binding of 3-quinuclidinyl benzilate and 5-hydroxytryptamine will be monitored. Emphasis will be placed on whether the ethanol-drug combination is synergistic, additive, or antagonistic in altering structure, function or both. Significant correlations between changes in biomembrane structure and enzymatic activity or receptor binding will suggest a more general involvement of membrane structure in such changes versus enzyme or receptor specific alterations. The determination of the effects of perturbants on the structural parameters of protein-free phospholipid vesicles formed from extracts of plasma membranes and from commercial sources will further distinguish between membrane-perturbant in contrast with protein-perturbant interactions. This study should enhance our understanding of the heretofore sparsely investigated response of biomembranes to simultaneous exposure to ethanol and other drugs. It will explore the hypothesis that part of the potentiating effects of simultaneously administered drugs on the higher functions of complex organisms orginates with synergistic changes in membrane structure. Furthermore, it may find an enzyme or receptor which might be particularly susceptible to the combination of ethanol and a drug in low (possibly clinically relevant) concentrations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Unknown (R23)
Project #
7R23AA006935-01
Application #
3445272
Study Section
Alcohol Biomedical Research Review Committee (ALCB)
Project Start
1985-09-01
Project End
1987-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
Schools of Arts and Sciences
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Carfagna, M A; Ponsler, G D; Muhoberac, B B (1996) Inhibition of ATPase activity in rat synaptic plasma membranes by simultaneous exposure to metals. Chem Biol Interact 100:53-65
Carfagna, M A; Muhoberac, B B (1993) Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K(+)-ATPase activity. Mol Pharmacol 44:129-41
Moubarak, A S; Muhoberac, B B (1991) The interaction of thioridazine with cardiac cytochrome oxidase;enzyme activity and drug binding studies. Biochem Biophys Res Commun 179:1063-9
Steup, M B; Muhoberac, B B (1989) Preparation and spectral characterization of the heme d1.apomyoglobin complex: an unusual protein environment for the substrate-binding heme of Pseudomonas cytochrome oxidase. J Inorg Biochem 37:233-57
Sattin, A; Muhoberac, B B; Aprison, M H et al. (1989) Tetrahydroaminoacridine (THA) as a pharmacological probe in Alzheimer's disease (AD) and other neurodegenerative disorders. Med Hypotheses 29:155-9
Muhoberac, B B; Hanew, T; Halter, S et al. (1989) A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administration. Biochem Pharmacol 38:4103-13
Muhoberac, B B; Burch, M K; Morgan, W T (1988) Paramagnetic probes of the domain structure of histidine-rich glycoprotein. Biochemistry 27:746-52
Burch, M K; Muhoberac, B B; Morgan, W T (1988) Characterization of Cu2+ and Fe3+ -mesoporphyrin complexes with histidine-rich glycoprotein: evidence for Cu2+ -Fe3+ -mesoporphyrin interaction. J Inorg Biochem 34:135-48
Muhoberac, B B; Shelnutt, J A; Ondrias, M R (1988) A resonance Raman study of the binding of ethanol and methanol to ferrihemoglobin. FEBS Lett 228:310-6